The authors declare the following competing interest, which should have been declared at the time of publication. Pamela L. St. Jean, Pierandrea Muglia, and Clyde Francks are full-time employees of GlaxoSmithKline, a pharmaceutical company that is developing treatments for schizophrenia and that has filed patent applications for SNPs related to schizophrenia (United States Patent Applications 20080176239 and 20080176240, and International Application No.: PCT/EP2008/050477).
Citation: Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, et al. (2009) Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia. PLoS Genet 5(3): 10.1371/annotation/e0196ebb-de40-453f-8f8c-791b126618da. https://doi.org/10.1371/annotation/e0196ebb-de40-453f-8f8c-791b126618da
Published: March 24, 2009
Copyright: © 2009 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.